Elcan Patricia F reported other involving 886,871 shares of HCA Healthcare, Inc. at $503.53 for −$447M on Nov 4, 2026

Other
Form 4 code J. Other acquisition or disposition. The filer must describe the transaction.
10% owner
10%
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$446,561,720.28Shares × reported price
Shares traded
886,871Common Stock, par value $0.01 per share
Price per share
$503.53Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
32,282,889Indirect · By Hercules Holding II
Trade date
Nov 4, 2026Other
Filed
Nov 6, 2026, 6:06 PM ET2-day reporting delay
Accession
0001140361-26-042526Code J · Transaction 395268
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Other886,871$503.53$446,561,720.28Trade 395269
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

HCA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HCA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −12%1w ago −12%1d ago −6.5%
Returns since7d +0.8%30d90d180d1y

Footnotes in full

F1: Hercules Holding II ("Hercules") holds 32,282,889 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"). Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of her pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 357,510 Shares by the Reporting Person; 84,306 Shares by the Reporting Person's spouse; and 9,832,500 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee. F2: These Shares are held jointly with the Reporting Person's spouse. F3: Frisco Holding II ("Frisco") holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of her pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,971,002 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee. F4: These Shares are held by trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee. F5: On November 4, 2026, the Reporting Person transferred a total 47,002 units of Hercules to trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee in satisfaction of obligations owed by the Reporting Person (with respect to 20,191 units) and in exchange for assets of equal value (with respect to 26,811 units), and trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee transferred a total of 839,869 units of Hercules to trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee in satisfaction of obligations. Each of these transfers was made at a price per unit of Hercules equal to $503.525 (the average of the high and low prices of the Shares on November 4, 2026). In each case, these transfers did not change the total number of Shares of which the Reporting Person may be deemed to have beneficial ownership.